Selinexor, Physician's Choice Treatment — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-09 (month) in 2mo
ESTIMATED |
READOUT
A Study to Evaluate Single Agent Selinexor Versus Physician's Choice in Particip
Phase 2 · Myelofibrosis |
KPTI Karyopharm Therapeutics Inc. | Selinexor, Physician's Choice Treatment |
ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
|